Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) & Region - Global Forecast to 2027
Market Growth Outlook Summary
The global pharmacy automation market growth forecasted to transform from $5.6 billion in 2022 to $8.2 billion by 2027, driven by a CAGR of 7.9%. Growth in the market is mainly driven by the growing focus on automation to reduce labor costs, and increasing specialty drug dispensing. Moreover, pharmacy automation companies are seeking new opportunities by expanding their presence across emerging economies. However, the high costs of implementing pharmacy automation systems and stringent regulations that delay product launches can inhibit the growth of pharmacy automation devices market.
Pharmacy Automation Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Pharmacy Automation Market Dynamics
Driver: Growing need to minimize medication errors
Medication errors and dispensing errors are recognized as leading causes of hospital readmission across the globe. Poor order communication between physicians and pharmacists, dangerous storage practices in pharmacies, and the confusion arising from similar labels and drug prescriptions during the preparation or dispensing of drugs or during drug administration are some key factors contributing to medication errors. Automated systems are considered one of the most efficient solutions to minimize these errors. In the past, the successful implementation of automated dispensing cabinets (ADCs) and automated dispensing machines (ADMs) in hospitals led to significant reductions in the number of dispensing and medication errors in hospitals.
Restraint: High initial capital investments
Despite their benefits, several healthcare professionals and providers are reluctant to adopt or accept IT-based approaches to pharmacy management. This is particularly evident when cultural barriers are involved, especially in emerging economies. Therefore, many pharmacists do not want assistance and are reluctant to adopt pharmacy automation systems as part of their dispensing regimen. Although the benefits of automated pharmacy systems are considerable and the extensive adoption of technology verifies this, until now, only large-volume pharmacies and hospitals could justify the returns on investment (ROIs) obtained from installing these automated systems.
Opportunity: Untapped emerging markets
Emerging economies are expected to become a focal point for growth in the pharmacy automation devices market. Developing countries possess a high geriatric population. According to the UN report on World Population Ageing (2019), Eastern and Southeastern Asia are expected to experience a two-fold increase in the number of geriatric individuals, with the population aged 65 years or over projected to increase from 260.6 million in 2019 to nearly 572.5 million by 2050. This demographic trend is expected to increase the patient volume in several Asian countries and drive the demand for quality patient care and efficient medication dispensing. As a result, the demand for pharmacy automation systems in several Asian countries is expected to increase in the coming years.
Challenge: Stringent regulatory procedures
The stringency of regulatory approvals depends on the class to which a particular device belongs; it may vary from one region to another. Several state boards of pharmacies (agencies of a state responsible for the control and regulation of the practice of a pharmacy and the licensing of pharmacists in the state) have different requirements for using automated dispensing devices (ADDs) in healthcare practices. Thus, manufacturers of automated systems for pharmacies have to adhere to various regulations; ensuring such compliance is a tedious task and can delay product launches.
The pharmacy packaging and labelling system segment of pharmacy automation market is expected to have the highest CAGR during the forecast period
Based on products, the market is segmented into automated medication dispensing and storage systems, automated packaging and labeling systems, automated tabletop counters, automated medication compounding systems, and other pharmacy automation systems. The pharmacy packaging and labelling system segment is expected to register the highest growth during the forecast period. This is mainly due to the need to improve dispensing accuracy & productivity and lower the overall cost of the process by helping its users avoid such confusions by providing all medications with clear labels and distinct appearances.
Centralized pharmacies segment of pharmacy automation market accounted for the largest share of the automated medication dispensing and storage systems market
Based on applications/operations, the market is segmented into centralized and decentralized pharmacies. Centralized pharmacies accounted for the largest share of the global automated medication dispensing and storage systems market. This can be attributed to the high adoption of centralized models for end-to-end medication dispensing in hospitals, pharmacies, and nursing units.
The inpatient pharmacies segment accounted for the largest share of pharmacy automation market
Based on end users, the market is segmented into inpatient pharmacies, outpatient pharmacies, retail pharmacies, and pharmacy benefit management organizations and mail-order pharmacies. Inpatient pharmacies accounted for the largest share of this market. This is mainly due to the advantage of faster dispensing of medications within hospital facilities as compared to the traditional manual methods.
Asia Pacific region of pharmacy automation market is expected to register the highest CAGR during the forecast period
North America accounted for the largest share of the market. However, the market in the Asia Pacific is expected to register the highest growth during the forecast period. This can be attributed to the rising demand for health technology solutions and the growing number of companies setting up manufacturing units in APAC countries.
To know about the assumptions considered for the study, download the pdf brochure
The prominent players in the pharmacy automation market include Becton, Dickinson and Company (US), Omnicell, Inc. (US), KUKA AG (Swisslog Healthcare) (Germany), Baxter International Inc. (US), Capsa Healthcare (US), Cerner Corporation (US), Yuyama Co., Ltd. (Japan), ARxIUM Inc. (US), Parata Systems, LLC (US), RxSafe, LLC (US), and ScriptPro LLC (US).
Scope of the Pharmacy Automation Industry
|
Report Metric |
Details |
|
Market Revenue Size in 2022 |
$5.6 billion |
|
Projected Revenue Size by 2027 |
$8.2 billion |
|
Industry Growth Rate |
Poised to Grow at a CAGR of 7.9% |
|
Market Driver |
Growing need to minimize medication errors |
|
Market Opportunity |
Untapped emerging markets |
The study categorizes the pharmacy automation market to forecast revenue and analyze trends in each of the following submarkets:
By Product
-
Automated Medication Dispensing and Storage Systems
-
Automated Medication Dispensing and Storage Systems, by Type
- Robots/Robotic Automated Dispensing Systems
- Carousels
- Automated Dispensing Cabinets
-
Automated Medication Dispensing and Storage Systems, By Application/Operation
- Centralized Pharmacies
- Decentralized Pharmacies
-
Automated Medication Dispensing and Storage Systems, by Type
- Automated Packaging and Labelling Systems
- Automated Tabletop Counters
- Automated Medication Compounding Systems
- Other Pharmacy Automation Systems
By End User
-
Inpatient Pharmacies
- Acute Care Systems
- Long Term Care Facilities
-
Outpatient Pharmacies
- Outpatient/Fast-Track Clinics
- Hospital Retail Settings
- Retail Pharmacies
- Pharmacy Benefit Management Organizations and Mail-Order Pharmacies
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- Japan
- China
- India
- Rest of APAC
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Recent Developments:
- In 2022, Capsa Healthcare announced the acquisition of Humanscale Healthcare (US), a designer and manufacturer of flexible technology solutions and computing workstations based in New York. Combined, Capsa now offers the broadest product suite in the market and expands its ability to provide ergonomically tailored point-of-care computing solutions to healthcare partners worldwide.
- In 2022, Capsa Healthcare (US) announced an expansion to its suite of NexsysADC automated dispensing cabinets. NexsysADC can accommodate any size of controlled or high-value medications or supplies in two new sizes of Controlled Access Module Drawers.
- In 2021, Innovation Associates (US) launched SmartPod, a next-generation robot for central-fill pharmacy environments. SmartPod allows providers to adjust and scale their centralized fulfillment solutions to meet demands.
- In 2021, Omnicell, Inc. (US) acquired ReCept Holdings, Inc., (US) along with its specialty pharmacy management services for health systems, provider groups, and federally qualified health centers (FQHCs), to expand its Advanced Services portfolio.
- In 2021, Swisslog Healthcare entered into an innovation agreement with Centre Hospitalier - Le Mans to synergize their expertise in the pharmacy field through the automated packaging and dispensing system, TheraPick.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global pharmacy automation market?
The global pharmacy automation market boasts a total revenue value of $8.2 billion by 2027.
What is the estimated growth rate (CAGR) of the global pharmacy automation market?
The global market for pharmacy automation has an estimated compound annual growth rate (CAGR) of 7.9% and a revenue size in the region of $5.6 billion in 2022.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 21)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKET SEGMENTATION
FIGURE 1 PHARMACY AUTOMATION MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 26)
2.1 RESEARCH APPROACH
FIGURE 2 PHARMACY AUTOMATION MARKET: RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION
FIGURE 8 TOP-DOWN APPROACH
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 10 CAGR PROJECTIONS
2.3 DATA TRIANGULATION APPROACH
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: PHARMACY AUTOMATION MARKET
3 EXECUTIVE SUMMARY (Page No. - 38)
FIGURE 12 PHARMACY AUTOMATION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 13 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS, BY APPLICATION/OPERATION, 2022 VS. 2027 (USD MILLION)
FIGURE 15 MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE MARKET
4 PREMIUM INSIGHTS (Page No. - 42)
4.1 PHARMACY AUTOMATION MARKET OVERVIEW
FIGURE 17 GROWING NEED TO MINIMIZE MEDICATION ERRORS AND REDUCE HEALTHCARE COSTS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: MARKET, BY PRODUCT AND COUNTRY (2021)
FIGURE 18 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS TO DOMINATE THE ASIA PACIFIC MARKET IN 2021
4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 CHINA TO REGISTER THE HIGHEST GROWTH IN THE MARKET DURING THE FORECAST PERIOD
4.4 MARKET, BY REGION (2020–2027)
FIGURE 20 NORTH AMERICA TO DOMINATE THE PHARMACY AUTOMATION DEVICES MARKET IN 2027
4.5 MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 46)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 PHARMACY AUTOMATION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing need to minimize medication errors
5.2.1.2 Decentralization of pharmacies
5.2.1.3 Rising geriatric population leading to increased adoption of automated dispensing systems
FIGURE 23 GLOBAL GERIATRIC POPULATION (65 YEARS & ABOVE), BY REGION
5.2.1.4 Growing focus on automation to reduce labor costs
5.2.1.5 Increasing specialty drug dispensing
TABLE 3 IMPACT ANALYSIS: MARKET DRIVERS
5.2.2 RESTRAINTS
5.2.2.1 Reluctance to adopt pharmacy automation systems
5.2.2.2 High initial capital investments
5.2.2.3 Lack of skilled personnel
TABLE 4 IMPACT ANALYSIS: MARKET RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing awareness among pharmacists
5.2.3.2 Untapped emerging markets
5.2.3.3 Healthcare cost-reduction measures
TABLE 5 IMPACT ANALYSIS: MARKET OPPORTUNITIES
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory procedures
5.2.4.2 Risk of cross-contamination
TABLE 6 IMPACT ANALYSIS: MARKET CHALLENGES
5.3 KEY CONFERENCES & EVENTS
TABLE 7 PHARMACY AUTOMATION MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.4 INDUSTRY TRENDS
5.4.1 SOFTWARE CONFIGURATIONS IN A SMALLER FOOTPRINT
5.4.2 PHARMACY ROBOTICS
5.4.3 RADIOFREQUENCY IDENTIFICATION (RFID) IN PHARMACY AUTOMATION
TABLE 8 EXAMPLES OF RFID IN PHARMACY AUTOMATION SYSTEMS
5.4.4 ELECTRONIC HEALTH RECORD INTEGRATION AND INTEROPERABILITY THROUGH PHARMACY AUTOMATION SYSTEMS
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 9 PORTER’S FIVE FORCES ANALYSIS
5.5.1 THREAT FROM NEW ENTRANTS
5.5.2 THREAT FROM SUBSTITUTES
5.5.3 BARGAINING POWER OF SUPPLIERS
5.5.4 BARGAINING POWER OF BUYERS
5.5.5 INTENSITY OF COMPETITIVE RIVALRY
5.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 REGULATORY ANALYSIS
5.7.1 NORTH AMERICA
5.7.1.1 US
5.7.1.2 Canada
5.7.2 EUROPE
5.7.3 ASIA PACIFIC
5.7.3.1 India
5.7.3.2 Australia
5.8 VALUE CHAIN ANALYSIS
FIGURE 24 VALUE CHAIN: PHARMACY AUTOMATION MARKET
5.9 TECHNOLOGY ANALYSIS
TABLE 11 TECHNOLOGY AND INNOVATION IN THE PHARMACY AUTOMATION DEVICES MARKET
5.10 PATENT ANALYSIS
5.10.1 PATENT PUBLICATION TRENDS FOR PHARMACY AUTOMATION SYSTEMS
FIGURE 25 PATENT PUBLICATION TRENDS (2011–APRIL 2022)
5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 26 TOP PATENT APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PHARMACY AUTOMATION SYSTEMS (JANUARY 2011–APRIL 2022)
FIGURE 27 TOP APPLICANT JURISDICTIONS FOR PHARMACY AUTOMATION SYSTEM PATENTS (JANUARY 2011–APRIL 2022)
TABLE 12 LIST OF PATENTS/PATENT APPLICATIONS IN THE PHARMACY AUTOMATION DEVICES MARKET, 2021–2022
5.11 ECOSYSTEM ANALYSIS
FIGURE 28 MARKET: ECOSYSTEM ANALYSIS
5.12 IMPACT OF COVID-19 ON THE PHARMACY AUTOMATION MARKET
6 PHARMACY AUTOMATION DEVICES MARKET, BY PRODUCT (Page No. - 69)
6.1 INTRODUCTION
TABLE 13 PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS
TABLE 14 POPULAR AUTOMATED MEDICATION DISPENSING SYSTEMS AVAILABLE IN THE MARKET
TABLE 15 POPULAR AUTOMATED MEDICATION STORAGE SYSTEMS AVAILABLE IN THE MARKET
TABLE 16 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS, BY TYPE
TABLE 17 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2.1.1 Robots/robotic automated dispensing systems
6.2.1.1.1 High adoption of robots to reduce dispensing errors in hospitals to drive market growth
TABLE 18 POPULAR ROBOTS/ROBOTIC AUTOMATED DISPENSING SYSTEMS AVAILABLE IN THE MARKET
TABLE 19 ROBOTS/ROBOTIC AUTOMATED DISPENSING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.2 Carousels
6.2.1.2.1 Improved inventory control and workflow to drive market growth during the forecast period
TABLE 20 POPULAR CAROUSEL SYSTEMS AVAILABLE IN THE MARKET
TABLE 21 CAROUSELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.3 Automated dispensing cabinets
6.2.1.3.1 Secured medication storage and tracking of drugs to propel the demand for automated dispensing cabinets
TABLE 22 POPULAR AUTOMATED DISPENSING CABINETS AVAILABLE IN THE MARKET
TABLE 23 AUTOMATED DISPENSING CABINETS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS, BY APPLICATION/OPERATION
TABLE 24 AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
6.2.2.1 Centralized pharmacies
6.2.2.1.1 Rising demand for centralized pharmacies to optimize inventory levels and reduce stock-outs to support the growth of this market segment
TABLE 25 CENTRALIZED PHARMACIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2.2 Decentralized pharmacies
6.2.2.2.1 Preference for improved patient safety to drive the market growth
TABLE 26 DECENTRALIZED PHARMACIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 AUTOMATED PACKAGING AND LABELING SYSTEMS
6.3.1 NEED TO IMPROVE DISPENSING ACCURACY AND LOWER THE OVERALL COST IS A MAJOR DRIVER FOR THE AUTOMATED PACKAGING AND LABELING SYSTEMS MARKET
TABLE 27 POPULAR AUTOMATED PACKAGING AND LABELING SYSTEMS CURRENTLY AVAILABLE IN THE MARKET
TABLE 28 AUTOMATED PACKAGING AND LABELING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 AUTOMATED TABLETOP COUNTERS
6.4.1 WITH AN INCREASED NUMBER OF PATIENTS VISITING PHARMACIES, AUTOMATED TABLETOP COUNTERS ARE NEEDED TO BOOST OPERATING SPEEDS
TABLE 29 POPULAR AUTOMATED TABLETOP COUNTERS CURRENTLY AVAILABLE IN THE MARKET
TABLE 30 AUTOMATED TABLETOP COUNTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 AUTOMATED MEDICATION COMPOUNDING SYSTEMS
6.5.1 AUTOMATED MEDICATION COMPOUNDING SYSTEMS REDUCE THE COST PER DOSE OF MEDICATION AND THE NEED FOR MEDICATION OUTSOURCING
TABLE 31 POPULAR AUTOMATED COMPOUNDING SYSTEMS CURRENTLY AVAILABLE IN THE MARKET
TABLE 32 AUTOMATED MEDICATION COMPOUNDING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6 OTHER PHARMACY AUTOMATION SYSTEMS
TABLE 33 OTHER PHARMACY AUTOMATION SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 PHARMACY AUTOMATION DEVICES MARKET, BY END USER (Page No. - 87)
7.1 INTRODUCTION
TABLE 34 MARKET, BY END USER, 2020–2027 (USD MILLION)
7.2 INPATIENT PHARMACIES
TABLE 35 PHARMACY AUTOMATION SOLUTIONS USED FOR HOSPITAL INPATIENT PHARMACIES
TABLE 36 MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 37 MARKET FOR INPATIENT PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1 ACUTE CARE SYSTEMS
7.2.1.1 Increasing healthcare spending to increase the adoption of technology solutions in acute care settings—a key factor driving market growth
TABLE 38 MARKET FOR ACUTE CARE SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2 LONG-TERM CARE FACILITIES
7.2.2.1 Growing geriatric population to drive the adoption of pharmacy technology solutions
TABLE 39 PHARMACY AUTOMATION SOLUTIONS FOR LONG-TERM CARE FACILITIES
TABLE 40 MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 OUTPATIENT PHARMACIES
TABLE 41 PHARMACY AUTOMATION SOLUTIONS USED IN OUTPATIENT PHARMACIES
TABLE 42 MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 43 MARKET FOR OUTPATIENT PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1 OUTPATIENT/FAST-TRACK CLINICS
7.3.1.1 Growing need to minimize medication dispensing errors in outpatient clinics will increase the adoption of pharmacy automation systems
TABLE 44 MARKET FOR OUTPATIENT/FAST-TRACK CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2 HOSPITAL RETAIL SETTINGS
7.3.2.1 Need for accurate medication dispensing and faster inventory management to drive market growth
TABLE 45 MARKET FOR HOSPITAL RETAIL SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 RETAIL PHARMACIES
7.4.1 GROWING NEED FOR TECHNOLOGY TO ASSIST WITH FASTER PRESCRIPTION FILLING AND MEDICATION DISPENSING TO DRIVE MARKET GROWTH
TABLE 46 MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND MAIL-ORDER PHARMACIES
7.5.1 NEED FOR STREAMLINING PHARMACY OPERATIONS AND ENSURING FASTER WORKFLOWS WILL DRIVE MARKET GROWTH
TABLE 47 PHARMACY AUTOMATION SOLUTIONS USED IN MAIL-ORDER PHARMACIES
TABLE 48 MARKET FOR PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND MAIL-ORDER PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION)
8 PHARMACY AUTOMATION DEVICES MARKET, BY REGION (Page No. - 102)
8.1 INTRODUCTION
FIGURE 29 MARKET: GEOGRAPHIC SNAPSHOT (2021)
TABLE 49 MARKET, BY REGION, 2020–2027 (USD MILLION)
8.2 IMPACT OF COVID-19 ON THE MARKET, BY COUNTRY/REGION
8.3 NORTH AMERICA
FIGURE 30 NORTH AMERICA: MARKET SNAPSHOT
TABLE 50 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 51 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 52 NORTH AMERICA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 NORTH AMERICA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 54 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 55 NORTH AMERICA: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 NORTH AMERICA: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.3.1 US
8.3.1.1 Advanced medical infrastructure and increasing healthcare expenditure to drive market growth in the US
TABLE 57 US: KEY MACROINDICATORS
TABLE 58 US: PHARMACY AUTOMATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 59 US: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 60 US: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 61 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 62 US: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 63 US: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.3.2 CANADA
8.3.2.1 Growing adoption of technologically advanced healthcare solutions to propel market growth in Canada
TABLE 64 CANADA: KEY MACROINDICATORS
TABLE 65 CANADA: PHARMACY AUTOMATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 66 CANADA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 CANADA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 68 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 69 CANADA: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 70 CANADA: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.4 EUROPE
TABLE 71 EUROPE: PHARMACY AUTOMATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 72 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 73 EUROPE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 EUROPE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 75 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 76 EUROPE: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 EUROPE: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.4.1 GERMANY
8.4.1.1 Increasing healthcare expenditure and growing adoption of healthcare technology to drive market growth in Germany
TABLE 78 GERMANY: KEY MACROINDICATORS
TABLE 79 GERMANY: PHARMACY AUTOMATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 80 GERMANY: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 GERMANY: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 82 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 83 GERMANY: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 84 GERMANY: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.4.2 UK
8.4.2.1 Rising government initiatives to drive market growth in the UK
TABLE 85 UK: KEY MACROINDICATORS
TABLE 86 UK: PHARMACY AUTOMATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 87 UK: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 UK: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 89 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 90 UK: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 UK: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.4.3 FRANCE
8.4.3.1 High healthcare spending and favorable government initiatives to drive market growth in France
TABLE 92 FRANCE: KEY MACROINDICATORS
TABLE 93 FRANCE: PHARMACY AUTOMATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 94 FRANCE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 FRANCE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 96 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 97 FRANCE: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 FRANCE: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.4.4 ITALY
8.4.4.1 Initiatives toward medical technology and automation implementation to propel market growth in Italy
TABLE 99 ITALY: KEY MACROINDICATORS
TABLE 100 ITALY: PHARMACY AUTOMATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 101 ITALY: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 ITALY: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 103 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 104 ITALY: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 ITALY: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.4.5 SPAIN
8.4.5.1 Increasing focus on improving the healthcare infrastructure and growing geriatric population to support the market growth
TABLE 106 SPAIN: KEY MACROINDICATORS
TABLE 107 SPAIN: PHARMACY AUTOMATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 108 SPAIN: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 SPAIN: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 110 SPAIN: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 111 SPAIN: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 SPAIN: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.4.6 REST OF EUROPE
TABLE 113 ROE: PHARMACY AUTOMATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 114 ROE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 ROE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 116 ROE: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 117 ROE: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 ROE: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.5 ASIA PACIFIC
FIGURE 31 ASIA PACIFIC: PHARMACY AUTOMATION MARKET SNAPSHOT
TABLE 119 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 120 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 121 ASIA PACIFIC: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 ASIA PACIFIC: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 123 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 124 ASIA PACIFIC: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 ASIA PACIFIC: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.5.1 JAPAN
8.5.1.1 Large geriatric population in the country drives the demand for pharmacy automated systems
TABLE 126 JAPAN: KEY MACROINDICATORS
TABLE 127 JAPAN: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 128 JAPAN: AUTOMATION MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 JAPAN: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 130 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 131 JAPAN: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 JAPAN: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.5.2 CHINA
8.5.2.1 Growing investments in healthcare infrastructure development in China to drive the market growth
TABLE 133 CHINA: KEY MACROINDICATORS
TABLE 134 CHINA: PHARMACY AUTOMATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 135 CHINA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 CHINA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 137 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 138 CHINA: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 CHINA: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.5.3 INDIA
8.5.3.1 Increasing healthcare investments will boost the demand for pharmacy automation systems in India
TABLE 140 INDIA: KEY MACROINDICATORS
TABLE 141 INDIA: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 142 INDIA: AUTOMATION MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 INDIA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 144 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 145 INDIA: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 INDIA: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.5.4 REST OF ASIA PACIFIC
TABLE 147 ROAPAC: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 148 ROAPAC: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 ROAPAC: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 150 ROAPAC: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 151 ROAPAC: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 ROAPAC: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.6 LATIN AMERICA
TABLE 153 LATIN AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 154 LATIN AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 155 LATIN AMERICA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 156 LATIN AMERICA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 157 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 158 LATIN AMERICA: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 LATIN AMERICA: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.6.1 BRAZIL
8.6.1.1 Brazil accounted for the largest share of the LATAM market in 2021
TABLE 160 BRAZIL: KEY MACROINDICATORS
TABLE 161 BRAZIL: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 162 BRAZIL: AUTOMATION MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 163 BRAZIL: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 164 BRAZIL: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 165 BRAZIL: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 BRAZIL: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.6.2 MEXICO
8.6.2.1 Need to reduce medication errors and the rising geriatric population to drive market growth
TABLE 167 MEXICO: KEY MACROINDICATORS
TABLE 168 MEXICO: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 169 MEXICO: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 MEXICO: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 171 MEXICO: PHARMACY AUTOMATION DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 172 MEXICO: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 173 MEXICO: PHARMACY AUTOMATION DEVICES MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.6.3 REST OF LATIN AMERICA
TABLE 174 ROLATAM: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 175 ROLATAM: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 176 ROLATAM: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 177 ROLATAM: MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 178 ROLATAM: MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 ROLATAM: MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.7 MIDDLE EAST & AFRICA
8.7.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
TABLE 180 SAUDI ARABIA: KEY MACROINDICATORS
TABLE 181 SOUTH AFRICA: KEY MACROINDICATORS
TABLE 182 MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 183 MIDDLE EAST & AFRICA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 MIDDLE EAST & AFRICA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
TABLE 185 MIDDLE EAST & AFRICA: PHARMACY AUTOMATION DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)
TABLE 186 MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 187 MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
9 COMPETITIVE LANDSCAPE (Page No. - 167)
9.1 OVERVIEW
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 188 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE PHARMACY AUTOMATION MARKET
9.3 KEY STAKEHOLDERS & BUYING CRITERIA
9.3.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS
TABLE 189 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 PHARMACY AUTOMATION SYSTEMS
9.3.2 BUYING CRITERIA
FIGURE 33 KEY BUYING CRITERIA FOR THE TOP 3 PHARMACY AUTOMATION SYSTEMS
TABLE 190 KEY BUYING CRITERIA FOR THE TOP 3 PHARMACY AUTOMATION SYSTEMS
9.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN THE PHARMACY AUTOMATION DEVICES MARKET
9.5 MARKET SHARE ANALYSIS
FIGURE 35 PHARMACY AUTOMATION MARKET SHARE, BY KEY PLAYER, 2021
TABLE 191 PHARMACY AUTOMATION MARKET: DEGREE OF COMPETITION
9.6 COMPETITIVE BENCHMARKING
TABLE 192 FOOTPRINT OF COMPANIES IN THE PHARMACY AUTOMATION DEVICES MARKET
9.6.1 PRODUCT FOOTPRINT
TABLE 193 PRODUCT FOOTPRINT OF COMPANIES (20 COMPANIES)
9.6.2 END-USER FOOTPRINT
TABLE 194 END-USER FOOTPRINT OF COMPANIES (20 COMPANIES)
9.6.3 REGIONAL FOOTPRINT
TABLE 195 REGIONAL FOOTPRINT OF COMPANIES (20 COMPANIES)
9.7 COMPETITIVE LEADERSHIP MAPPING
9.7.1 STARS
9.7.2 EMERGING LEADERS
9.7.3 PERVASIVE PLAYERS
9.7.4 PARTICIPANTS
FIGURE 36 PHARMACY AUTOMATION MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
9.8 COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES
9.8.1 PROGRESSIVE COMPANIES
9.8.2 DYNAMIC COMPANIES
9.8.3 STARTING BLOCKS
9.8.4 RESPONSIVE COMPANIES
FIGURE 37 PHARMACY AUTOMATION MARKET: COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES (2021)
9.9 COMPETITIVE SCENARIO
9.9.1 PRODUCT LAUNCHES/UPGRADES
TABLE 196 PRODUCT LAUNCHES/APPROVALS/UPGRADES, 2019–2022
9.9.2 DEALS
TABLE 197 DEALS, 2019–2022
9.9.3 OTHER DEVELOPMENTS
TABLE 198 OTHER DEVELOPMENTS, 2019–2022
10 COMPANY PROFILES (Page No. - 185)
10.1 KEY PLAYERS
(Business overview, Products offered, Recent Developments, MNM view)*
10.1.1 BECKTON, DICKINSON AND COMPANY
TABLE 199 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 38 BECKTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
10.1.2 OMNICELL, INC.
TABLE 200 OMNICELL, INC.: BUSINESS OVERVIEW
FIGURE 39 OMNICELL, INC.: COMPANY SNAPSHOT (2021)
10.1.3 KUKA AKTIENGESELLSCHAFT (SWISSLOG HEALTHCARE)
TABLE 201 KUKA AKTIENGESELLSCHAFT: BUSINESS OVERVIEW
FIGURE 40 KUKA AKTIENGESELLSCHAFT: COMPANY SNAPSHOT (2021)
10.1.4 BAXTER INTERNATIONAL INC.
TABLE 202 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW
FIGURE 41 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2021)
10.1.5 CAPSA HEALTHCARE
TABLE 203 CAPSA HEALTHCARE: BUSINESS OVERVIEW
10.1.6 CERNER CORPORATION
TABLE 204 CERNER CORPORATION: BUSINESS OVERVIEW
FIGURE 42 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
10.1.7 YUYAMA CO., LTD.
TABLE 205 YUYAMA CO., LTD.: BUSINESS OVERVIEW
10.1.8 ARXIUM, INC.
TABLE 206 ARXIUM: BUSINESS OVERVIEW
10.1.9 PARATA SYSTEMS, LLC
TABLE 207 PARATA SYSTEMS: BUSINESS OVERVIEW
10.1.10 RXSAFE, LLC
TABLE 208 RXSAFE: BUSINESS OVERVIEW
10.1.11 SCRIPTPRO, LLC
TABLE 209 SCRIPTPRO, LLC: BUSINESS OVERVIEW
10.1.12 PEARSON MEDICAL TECHNOLOGIES, LLC
TABLE 210 PEARSON MEDICAL TECHNOLOGIES, LLC: BUSINESS OVERVIEW
10.1.13 MEDICAL PACKAGING INC., LLC
TABLE 211 MEDICAL PACKAGING INC., LLC: BUSINESS OVERVIEW
10.1.14 TENSION CORPORATION
TABLE 212 TENSION CORPORATION: BUSINESS OVERVIEW
10.1.15 NORITSU PHARMACY AUTOMATION
TABLE 213 NORITSU PHARMACY AUTOMATION: BUSINESS OVERVIEW
10.1.16 EUCLID MEDICAL PRODUCTS
TABLE 214 EUCLID MEDICAL PRODUCTS: BUSINESS OVERVIEW
10.1.17 TOUCHPOINT MEDICAL SOLUTIONS
TABLE 215 TOUCHPOINT MEDICAL SOLUTIONS: BUSINESS OVERVIEW
10.1.18 MEDITECH PHARMACY MANAGEMENT SOLUTIONS
TABLE 216 MEDITECH PHARMACY MANAGEMENT SOLUTIONS: BUSINESS OVERVIEW
10.1.19 INNOVATION ASSOCIATES
TABLE 217 INNOVATION ASSOCIATES: BUSINESS OVERVIEW
10.1.20 MCKESSON CORPORATION
TABLE 218 MCKESSON CORPORATION: BUSINESS OVERVIEW
FIGURE 43 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
10.2 OTHER PLAYERS
10.2.1 WILLACH GROUP: COMPANY OVERVIEW
10.2.2 STÄUBLI INTERNATIONAL: COMPANY OVERVIEW
10.2.3 MEDAVAIL: COMPANY OVERVIEW
10.2.4 PHARMACY AUTOMATION SYSTEM: COMPANY OVERVIEW
10.2.5 DEENOVA SRL: COMPANY OVERVIEW
11 APPENDIX (Page No. - 238)
11.1 INSIGHTS FROM INDUSTRY EXPERTS
11.2 DISCUSSION GUIDE
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.4 AVAILABLE CUSTOMIZATIONS
11.5 RELATED REPORTS
11.6 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global pharmacy automation market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply side and other participants were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, presidents, vice presidents, directors, marketing directors, marketing managers, and related executives from various key companies and organizations in the pharmacy automation industry . The primary sources from the other participants group including hospital personnel, C-level executives, department heads, hospital directors, long-term care center personnel, and pharmacists. And others including, private consultants, contract manufacturers, suppliers, distributers and officials from Government regulatory bodies.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product, end user and region).
Data Triangulation
After arriving at the market size, the total pharmacy automation market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.
Objectives of the Study
- To define, describe, segment, and forecast the pharmacy automation market by product, end user and by region.
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall pharmacy automation market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the pharmacy automation market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the pharmacy automation market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the pharmacy automation market
- To benchmark players within the pharmacy automation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering
- To evaluate and analyze the overall impact of COVID-19 on the pharmacy automation market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Geographic Analysis
- Further breakdown of the Rest of Europe pharmacy automation market into Switzerland, Russia, the Netherlands, Portugal, Poland, and Belgium
- Further breakdown of the Middle East and Africa pharmacy automation market into Saudi Arabia, UAE, and others.
Generating Response ...
Growth opportunities and latent adjacency in Pharmacy Automation Market